| Ident. | Authors (with country if any) | Title |
|---|
| 000120 (2017) |
Candace H. Carriere [Canada] ; Na Hyea Kang [Canada] ; Lennard P. Niles [Canada] | Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment. |
| 000127 (2017) |
Chi Wang Ip [Allemagne] ; Laura-Christin Klaus [Allemagne] ; Akua A. Karikari [Allemagne] ; Naomi P. Visanji ; Jonathan M. Brotchie ; Anthony E. Lang ; Jens Volkmann [Allemagne] ; James B. Koprich | AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease |
| 000623 (2015) |
Ali H. Rajput [Canada] ; Michele L. Rajput [Canada] ; Christopher A. Robinson [Canada] ; Alex Rajput [Canada] | Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations. |
| 000655 (2015) |
Kyle Farmer ; Catherine A. Smith ; Shawn Hayley ; Jeffrey Smith | Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease |
| 000716 (2015) |
C. Warren Olanow [États-Unis] ; Raymond T. Bartus [États-Unis] ; Tiffany L. Baumann [États-Unis] ; Stewart Factor [États-Unis] ; Nicholas Boulis [États-Unis] ; Mark Stacy [États-Unis] ; Dennis A. Turner [États-Unis] ; William Marks [États-Unis] ; Paul Larson [États-Unis] ; Phillip A. Starr [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard Simpson [États-Unis] ; Ray Watts [États-Unis] ; Barton Guthrie [États-Unis] ; Kathleen Poston [États-Unis] ; Jaimie M. Henderson [États-Unis] ; Matthew Stern [États-Unis] ; Gordon Baltuch [États-Unis] ; Christopher G. Goetz [États-Unis] ; Christopher Herzog [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; Ron Alterman [États-Unis] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. |
| 000A24 (2014) |
Yiming Xiao [Canada] ; Pierre Jannin ; Tiziano D'Albis ; Nicolas Guizard ; Claire Haegelen ; Florent Lalys ; Marc Vérin ; D Louis Collins | Investigation of morphometric variability of subthalamic nucleus, red nucleus, and substantia nigra in advanced Parkinson's disease patients using automatic segmentation and PCA-based analysis. |
| 000B98 (2014) |
YIMING XIAO [Canada] ; Pierre Jannin [France] ; Tiziano D'Albis [France] ; Nicolas Guizard [Canada] ; Claire Haegelen [France] ; Florent Lalys [France] ; Marc Verin [France] ; D. Louis Collins [Canada] | Investigation of Morphometric Variability of Subthalamic Nucleus, Red Nucleus, and Substantia Nigra in Advanced Parkinson's Disease Patients Using Automatic Segmentation and PCA-Based Analysis |
| 000C70 (2013) |
Mahan Alavi [Canada] ; Jonathan O. Dostrovsky ; Mojgan Hodaie ; Andres M. Lozano ; William D. Hutchison | Spatial extent of β oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients. |
| 001044 (2013) |
Mahan Alavi [Canada] ; Jonathan O. Dostrovsky [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Spatial extent of beta oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients |
| 001047 (2013) |
Raymond T. Bartus [États-Unis] ; Tiffany L. Baumann [États-Unis] ; Joao Siffert [États-Unis] ; Christopher D. Herzog [États-Unis] ; Ron Alterman [États-Unis] ; Nicholas Boulis [États-Unis] ; Dennis A. Turner [États-Unis] ; Mark Stacy [États-Unis] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; C. Warren Olanow [États-Unis] | Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients |
| 001833 (2011) |
L. Macgillivray [Canada] ; K. B. Reynolds [Canada] ; M. Sickand [Canada] ; P. I. Rosebush [Canada] ; M. F. Mazurek [Canada] | Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra |
| 001889 (2011) |
Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia |
| 001A27 (2010) |
Anna Wypijewska [Pologne] ; Jolanta Galazka-Friedman ; Erika R. Bauminger ; Zbigniew K. Wszolek ; Katherine J. Schweitzer ; Dennis W. Dickson ; Andrzej Jaklewicz ; Danek Elbaum ; Andrzej Friedman | Iron and reactive oxygen species activity in parkinsonian substantia nigra. |
| 001A38 (2010) |
Myriam Lafreniere-Roula [Canada] ; Elaine Kim ; William D. Hutchison ; Andres M. Lozano ; Mojgan Hodaie ; Jonathan O. Dostrovsky | High-frequency microstimulation in human globus pallidus and substantia nigra. |
| 001A47 (2010) |
James B. Koprich [Canada] ; Tom H. Johnston [Canada] ; M Gabriela Reyes [Canada] ; Xuan Sun [Canada] ; Jonathan M. Brotchie [Canada] | Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease |
| 001C79 (2010) |
Martin Parent [Canada] ; André Parent [Canada] | Substantia Nigra and Parkinson's Disease: A Brief History of Their Long and Intimate Relationship |
| 001D08 (2010) |
Myriam Lafreniere-Roula [Canada] ; Elaine Kim [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Mojgan Hodaie [Canada] ; Jonathan O. Dostrovsky [Canada] | High-frequency microstimulation in human globus pallidus and substantia nigra |
| 001E00 (2009) |
Mallika Somayajulu-Ni U [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Marianna Sikorska [Canada] ; Ts Sridhar [Canada, Inde] ; Anca Matei [Canada] ; Henryk Borowy-Borowski [Canada] ; Siyaram Pandey [Canada] | Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10 |
| 002092 (2009) |
Emily N. Mangano [Canada] ; Shawn Hayley [Canada] | Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration |
| 002296 (2008) |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys |
| 002A39 (2005) |
S. Jourdain [Canada] ; M. Morissette [Canada] ; N. Morin [Canada] ; T. Di Paolo [Canada] | Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mice |
